Live Breaking News & Updates on Donald Xu

Stay updated with breaking news from Donald xu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Collaboration brings DFU and Inflammatory Disease Therapy to Greater China Region

Aurealis Therapeutics, (Basel, Switzerland) and AI-based microbiome drug development company Xbiome have entered into an agreement for the clinical development and commercialisation of Aurealis’ investigational Diabetic Foot Ulcer (DFU) and other chronic wounds and inflammatory disease therapy in the Greater China territory. Click to read more. ....

Hong Kong , Macau General , Donald Xu , Roger Meier , Juha Yrj , Aurealis Therapeutics , Diabetic Foot Ulcer , Greater China , Mainland China , Lynx Financial , Aurealis Chairman , Bryan Tan , Managing Partner ,

AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China




AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

GlobeNewswire

December 22, 2021



Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class active immunotherapy with plans to. ....

United States , Hong Kong , Immunotherapies Saits , Richard Zhao , Donald Xu , Noel Barrett , Changjin Wang , Business Development Strategy , Frontier Biotechnologies Inc , Frontier Biotechnologies , Greater China , Lynx Financial , Managing Partner , European Journal , Clinical Pharmacology , Frontier Biotech , Business Development ,